Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 4 Interventional

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

ClinicalTrials.gov ID: NCT00011895

Public ClinicalTrials.gov record NCT00011895. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IV Multicenter Study of the Efficacy and Safety of 48-Week Induction Treatment With TRIZIVIR (Abacavir 300 Mg/Lamivudine 150 Mg/Zidovudine 300 Mg Combination Tablet BID) With Efavirenz (600 Mg QD) Followed by 48-Week Randomized, Open-Label, Maintenance Treatment With TRIZIVIR With or Without Efavirenz in HIV-1 Infected Antiretroviral Therapy Naive Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the effect of treatment with Trizivir (TZV) plus efavirenz (EFV) or TZV alone on viral load (level of HIV in the blood).

Study identification

NCT ID
NCT00011895
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 4
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
400 participants

Conditions and interventions

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2001 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

Started 2001

United States locations

U.S. sites
42
U.S. states
24
U.S. cities
36
Facility City State ZIP Site status
Phoenix Body Positive Phoenix Arizona 85006 —
Health for Life Clinic Little Rock Arkansas 72205 —
Orange County Ctr for Special Immunology Fountain Valley California 92708 —
Pacific Horizons Med Group San Francisco California 94115 —
Beacon Clinic / Boulder Community Hosp Boulder Colorado 80304 —
Georgetown Univ Med Ctr Washington D.C. District of Columbia 20007 —
Dupont Circle Physicians Group Washington D.C. District of Columbia 200091104 —
Infectious Disease Consultants Altamonte Springs Florida 32701 —
North Broward Hosp District / HIV Clinical Research Fort Lauderdale Florida 33311 —
Univ of Miami / Jackson Memorial Hosp Miami Florida 33136 —
SBMA Research Miami Beach Florida 33140 —
Infectious Disease Specialists of Atlanta Decatur Georgia 30033 —
Cook County Gen Hosp / Division of Infect Diseases Chicago Illinois 60612 —
Northstar Med Clinic Chicago Illinois 60657 —
University of Louisville / ID Division Louisville Kentucky 40202 —
HIV Outpatient Clinics / LA State Univ Med Ctr New Orleans Louisiana 70112 —
Boston Med Ctr Boston Massachusetts 02118 —
Dr Paul Benson Berkley Michigan 48072 —
Hennepin County Med Ctr Minneapolis Minnesota 55415 —
Regions Hosp / HIV/AIDS Program Saint Paul Minnesota 55101 —
CRC of Mississippi Jackson Mississippi 39202 —
Wellness Ctr / Las Vegas Las Vegas Nevada 89102 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
NJCRI Newark New Jersey 07103 —
SUNY / Health Sciences Ctr at Brooklyn Brooklyn New York 11203 —
Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ New York New York 10021 —
ID Consultants Charlotte North Carolina 28203 —
East Carolina Univ School of Medicine Greenville North Carolina 27858 —
Summa Health System Akron Ohio 44304 —
Univ of Oklahoma Infectious Disease Institute Oklahoma City Oklahoma 73117 —
Associates in Med and Mental Health Tulsa Oklahoma 74114 —
Univ of Tennessee Med Ctr at Knoxville Knoxville Tennessee 37920 —
Texas Tech Health Sciences Ctr El Paso Texas 79905 —
AIDS Outreach Center Fort Worth Texas 76104 —
Metroplex Infectious Disease Fort Worth Texas 76104 —
Tarrant County Infectious Diseases Associates Fort Worth Texas 76104 —
Therapeutic Concepts Houston Texas 77004 —
Diversified Med Practices, PA Houston Texas 77027 —
Infectious Diseases Associates of Houston Houston Texas 77030 —
Infectious Disease Physicians Inc Annandale Virginia 22003 —
Infectious Disease Consultants Fairfax Virginia 22030 —
Swedish Med Ctr Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00011895, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00011895 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →